Nutranomics, Inc. (NNRX)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Jun 26, 2025
Nutranomics Revenue
In the fiscal year ending July 31, 2020, Nutranomics had annual revenue of $871.00, down -98.54%.
Revenue
871.00
Revenue Growth
-98.54%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
1
Market Cap
16.75K
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 84.04M |
| Glass House Brands | 215.62M |
| American Oncology Network | 1.76B |
| Northwest Biotherapeutics | 1.47M |
| Silence Therapeutics | 27.70M |
Nutranomics News
- 2 years ago - NutraNomics Announces Exclusive Production Agreement with Premium Edibles Brand - Accesswire
- 2 years ago - The Plant Announces Strategic Business Alliance With RE Strategies, LLC - Accesswire
- 2 years ago - NutraNomics and The Plant Well Positioned for Growth Despite "Black Market" Competition - Accesswire
- 2 years ago - NutraNomics, Inc. and The Plant Announce Record October 2022 New Sales Bookings - Accesswire
- 2 years ago - NutraNomics Announces 109% Y/Y Growth for the Nine Months Ended September 30, 2022 - Accesswire
- 2 years ago - NutraNomics, Inc. and The Plant Announce Record Q3 2022 New Sales Bookings - Accesswire
- 3 years ago - NutraNomics Announces Debt Restructuring and New Credit Facility - Accesswire
- 3 years ago - NutraNomics, Inc. and The Plant Announce Distribution Expansion Into Northern California - Accesswire